Research article · 26 Jun 2018
Conference abstract
Serotonin system and autoimmunity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Considering both, our results and available literature reports, it seems that decresed platelet serotonin level (PSL) is a general finding in inflammatory rheumatic disorders including including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), mixed connective tissue disese (MCTD) and primary Sjogrenâ??s syndrome (pSS), signifying the role of the 5-HT in the pathogenesis of autoimmune rheumatic disorders including pSS. This could partially reflect increased 5-HT secretion during platelet activation in the acute stage of the disease. An inverse correlation between PSL and clinical disease activity was found in SLE, the lowest levels occurring in active stage of the disease. Absence of correlation between decreased PSL and increased release of other platelet granule constituents in RA and SLE, was reported. We have documented no correlation between magnitude of PSL reduction and clinical disease activity, indicating different biochemical , and/or genetic features of pSS, as pSS patients demonstrate a systemic inflammatory reaction of low-grade intensity. It is well known that the actions of 5-HT are primarily terminated by the membrane 5-HT transporter (5-HTT), and that 5-HTT gene (SLC6A4) could be a common genetic modulator of 5-HT transport. Overall, significant heterogeneity was observed among studies investigating the effects of the 5-HTT polymorphisms on PSL in healthy subjects and thus did not support the hypothesis that the 5-HTT variants have direct effect on PSL. In reviewing the literature, no data was found on the influence of the 5-HTTLPR, rs 25531 and 5-HTTVNTRin2 polymorphisms of 5-HTT gene on PSL in patients with pSS. Our results corroborate the findings of a great deal of the previous work, which did not demonstrate association between 5-HTTLPR variants and platelet 5-HT concentration in the group of healthy individuals. Potential functional consequences of both promoter and intronic 2 VNTR polymorphisms of the 5-HTT gene on PSL in pSS patients and healthy individuals, was documented. Significant association between PSL and 5-HTT gene variants was found, indicating that 5-HT system may play important role in the pathogenesis of pSS. Furthermore, reduction in pSL in a group of pSS patients with frequent episodic tensoion-type headache (FETH) correlated with number of white matter signal hyperintensities in pSS patients as compared to healthy controls, signifying a more widespread cerebral vasculopathy in pSS patients than in healthy individuals. We demonstrated here that additional mechanisms, such as impaired 5-HT transport can contribute to PSL reduction. However, absence of association between 5-HTT gene polymorphisms and PSL in healthy controls and the presence of the specific genotype 5-HTTVNTRin2 ss cannot provide the sole explanation for lower PSL. Reduced PSL may also be a consequence of activation of kynurenine-pathway-enzymes by proinflammatory cytokines, which then redirect tryptophan metabolism and affect 5-HT synthesis. 5-HT released by platelets helps drive the persistent vascular permeability via 5-HT elsewhere. Adequate level of vitamin D may be required to activate the transcription of the 5-HT-synthesizing gene tryptofan hydroxylase 2 (TPH2) in the brain and supresses the transcription of TPH1 in peripheral tissues, where when found in excess it promotes inflammation. Although DCs expressing 5-HT receptors are considered to play an important role in immune activation, the role of 5-HT system in modulating pDC function in the context of pSS inflammation remains to be determined. Thereby, altered 5-HT uptake by platelets can be a prerequisite for the decreased PSL, imlying that antidepressants (SSRI) used to treat depression by targeting 5-HTT may also target PSL in pSS.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 30 Sep 2024
The Role of the Immune System in Autoimmune Encephalitis
Short communication · 30 Sep 2023
Bilobalide's Promising Role in Autoimmune Encephalomyelitis and Peripheral Neuropathy: Modulating the Immune System and Protecting the Myelin Sheath
Editorial · 30 Jul 2023
Understanding Autoimmunity: When the Immune System Turns Against Itself
Short communication · 26 Jun 2023
Autoimmune Disorder that Affects the Central Nervous System
More from this journal
The newest in Neurological Disorders.
Commentary · 24 Feb 2026
Vertebrobasilar Dolichoectasia: A Meta-Analysis of Clinical Manifestations and Treatment Approaches
Commentary · 24 Feb 2026
Leveraging Multi-Dimensional Encoding in Single-Channel Haptic Feedback for Enhanced Two-Dimensional Control
Commentary · 24 Feb 2026
The Paradox of Seizure Frequency Reporting: Over counted, Underreported, and Its Clinical Implications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Helena Sarac”

